GR3035415T3 - Oral pharmaceutical compositions for specific colon delivery. - Google Patents

Oral pharmaceutical compositions for specific colon delivery.

Info

Publication number
GR3035415T3
GR3035415T3 GR20010400245T GR20010400245T GR3035415T3 GR 3035415 T3 GR3035415 T3 GR 3035415T3 GR 20010400245 T GR20010400245 T GR 20010400245T GR 20010400245 T GR20010400245 T GR 20010400245T GR 3035415 T3 GR3035415 T3 GR 3035415T3
Authority
GR
Greece
Prior art keywords
pharmaceutical compositions
oral pharmaceutical
core
colon delivery
specific colon
Prior art date
Application number
GR20010400245T
Other languages
English (en)
Inventor
Stefano Poli
Cesare Busetti
Luigi Moro
Original Assignee
Poli Ind Chimica Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11363431&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3035415(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Poli Ind Chimica Spa filed Critical Poli Ind Chimica Spa
Publication of GR3035415T3 publication Critical patent/GR3035415T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR20010400245T 1992-06-01 2001-02-14 Oral pharmaceutical compositions for specific colon delivery. GR3035415T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI921347A IT1260505B (it) 1992-06-01 1992-06-01 Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon

Publications (1)

Publication Number Publication Date
GR3035415T3 true GR3035415T3 (en) 2001-05-31

Family

ID=11363431

Family Applications (2)

Application Number Title Priority Date Filing Date
GR970401249T GR3023605T3 (en) 1992-06-01 1997-05-30 Oral pharmaceutical compositions for specific colon delivery
GR20010400245T GR3035415T3 (en) 1992-06-01 2001-02-14 Oral pharmaceutical compositions for specific colon delivery.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GR970401249T GR3023605T3 (en) 1992-06-01 1997-05-30 Oral pharmaceutical compositions for specific colon delivery

Country Status (8)

Country Link
EP (1) EP0572942B2 (el)
AT (1) ATE151285T1 (el)
DE (1) DE69309540T3 (el)
DK (1) DK0572942T4 (el)
ES (1) ES2101164T5 (el)
GR (2) GR3023605T3 (el)
HU (1) HUT75158A (el)
IT (1) IT1260505B (el)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6764697B1 (en) 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
US5686105A (en) * 1993-10-19 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
ES2068762B1 (es) * 1993-07-21 1995-12-01 Lipotec Sa Un nuevo preparado farmaceutico para mejorar la biodisponibilidad de drogas de dificil absorcion y procedimiento para su obtencion.
US5482718A (en) * 1994-03-23 1996-01-09 Hoffmann-La Roche Inc. Colon-targeted delivery system
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
GB9620709D0 (en) * 1996-10-04 1996-11-20 Danbiosyst Uk Colonic delivery of weak acid drugs
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
US5891474A (en) 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
NL1009107C2 (nl) 1997-11-12 1999-06-15 Banner Pharmacaps Inc Gelatine-uitspreidende doos met meervoudige, aanpasbare poortklep en meerlagig zacht gel.
US6531152B1 (en) 1998-09-30 2003-03-11 Dexcel Pharma Technologies Ltd. Immediate release gastrointestinal drug delivery system
UA74141C2 (uk) 1998-12-09 2005-11-15 Дж.Д. Сірл Енд Ко. Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти)
US6632451B2 (en) 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
CA2440641A1 (en) 2001-03-13 2002-09-19 Anand R. Baichwal Chronotherapeutic dosage forms containing glucocorticosteroid
FR2830446B1 (fr) * 2001-10-09 2004-02-06 Univ Pasteur Composition pharmaceutique destinee a liberer une substance active au niveau du colon
EP1558211A2 (en) * 2002-10-30 2005-08-03 Pharmacia Corporation Oral extended release tablets and methods of making and using the same
CU23334A1 (es) * 2003-03-20 2008-12-24 Inst Finlay Vacuna de vibrio cholerae inactivada en tabletas
NZ545921A (en) 2003-09-19 2009-09-25 Penwest Pharmaceuticals Co Delayed released dosage forms
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
ITMI20041295A1 (it) 2004-06-25 2004-09-25 Cosmo Spa Composizioni farmaceutiche antimicrobiche orali
EP1754471A1 (de) * 2005-08-18 2007-02-21 ORAMON-Arzneimittel GmbH & Co. KG Verwendung einer quellbaren Zwischenschicht zur Steuerung des Freisetzungsprofils einer festen Arzneimittelformulierung zur peroralen Anwendung und diese enthaltende Arzneimittelformulierung
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
GB0714030D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
GB0714029D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
CN102105140B (zh) * 2008-07-02 2013-10-23 巴斯夫欧洲公司 涂覆片剂的方法
IT1393244B1 (it) 2008-07-18 2012-04-12 Universita' Degli Studi Di Milano Sistema per il rilascio al colon di farmaci suscettibili di degradazione enzimatica e/o scarsamente assorbiti nel tratto gastrointestinale
EA021683B1 (ru) 2009-01-14 2015-08-31 Новакта Биосистемс Лимитед Производные деоксиактагардина в
NZ594675A (en) 2009-02-04 2013-11-29 Novacta Biosystems Ltd Actagardine derivatives
WO2015103447A1 (en) 2013-12-31 2015-07-09 Rapamycin Holdings, Llc Oral rapamycin nanoparticle preparations and use
GB201001688D0 (en) 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
MX2013001190A (es) 2010-07-29 2013-03-18 Cosmo Technologies Ltd Composiciones farmaceuticas y/o dieteticas con base en acidos grasos de cadena corta.
GB201013513D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
WO2013003697A1 (en) 2011-06-30 2013-01-03 Trustees Of Boston University Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
CN105073137A (zh) 2013-04-05 2015-11-18 波利化学公司 匹多莫德治疗肠易激综合症的用途
EP3131546B1 (en) 2014-04-16 2022-02-16 Rapamycin Holdings, Inc. Oral rapamycin preparation for use in treating feline chronic gingivo- stomatitis (fcgs)
CN105943505A (zh) * 2016-05-26 2016-09-21 杭州百诚医药科技股份有限公司 一种匹多莫德药物组合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4891223A (en) * 1987-09-03 1990-01-02 Air Products And Chemicals, Inc. Controlled release delivery coating formulation for bioactive substances
IT1230576B (it) * 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
US5032406A (en) † 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
PH27186A (en) * 1989-09-07 1993-04-16 Ciba Geigy Ag Double-coated granules of disodium pamidronate
DK469989D0 (da) † 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon

Also Published As

Publication number Publication date
ES2101164T5 (es) 2001-02-01
DK0572942T3 (da) 1997-10-20
HU9301577D0 (en) 1993-09-28
EP0572942A3 (en) 1994-08-24
ITMI921347A1 (it) 1993-12-02
DE69309540T3 (de) 2001-03-15
IT1260505B (it) 1996-04-09
DE69309540T2 (de) 1997-09-04
ES2101164T3 (es) 1997-07-01
ATE151285T1 (de) 1997-04-15
GR3023605T3 (en) 1997-08-29
HUT75158A (en) 1997-04-28
ITMI921347A0 (it) 1992-06-01
EP0572942A2 (en) 1993-12-08
EP0572942B1 (en) 1997-04-09
EP0572942B2 (en) 2000-11-29
DK0572942T4 (da) 2001-01-22
DE69309540D1 (de) 1997-05-15

Similar Documents

Publication Publication Date Title
EP0572942A3 (en) Oral pharmaceutical compositions for specific colon delivery
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
NO175186C (no) Fremgangsmåte for fremstilling av et osmotisk avgivende, oralt avleveringssystem inneholdende et moderat vannopplöselig, farmasöytisk akseptabelt salt av metoprolol
AU6770490A (en) Solid pharmaceutical compositions containing cimetidine
MY128809A (en) Pharmaceutical formulation of omeprazole
AU6892894A (en) Composition for preventing or treating a T cell mediated pathology or an unregulated T cell clonal replication comprising the amino acid sequence SGDQGGNE
ATE235507T1 (de) Neue aminosäurederivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
ES2036457A1 (es) Forma de dosificacion farmaceutica solida oral de liberacion programada y procedimiento de preparacion.
MX9605023A (es) Compuestos substituidos de imidazolidin-2,4-diona como substancias farmaceuticamente activas.
DK0637236T3 (da) Farmaceutisk præparat og fremgangsmåde til dets fremstilling
HK1032542A1 (en) Combination for the treatment of alcohol dependence containing an opioid antagonist and nmda receptor complex modulator
ZA965712B (en) New oxazolidinone derivatives, processes for the production thereof and pharmaceutical agents containing these compounds.
DE69631609D1 (en) Tricyclische erythromycinderivate
AU5794396A (en) Bisacodyl dosage form for colonic delivery
ATE149827T1 (de) Feste arzneimitteldosierungsform und methode zur verminderung des abriebs
GR3025951T3 (en) Alpha amino acid derivatives, a method for their preparation and pharmaceutical preparations containing them.
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
EP0572308A3 (fr) Dérivés hétérocycliques, leur procédé de préparation et les compositions qui les contiennent.
DE69634080D1 (de) Mittel zur verhinderung der truebung der vorderen linsenkapsel
ZA949347B (en) 1,4,7,10-tetraazacyclododecane derivatives, their use, pharmaceutical agents containing these compounds and process for their production.
EP0103858A3 (en) New peptides, process for preparation thereof and pharmaceutical compositions containing them
GR3029916T3 (en) A pharmaceutical form for the rectal administration of pharmacologically active compounds.
JO1821B1 (en) New pharmaceutical product
ATE10933T1 (de) Neues peptid, verfahren zu dessen herstellung und pharmazeutische zusammensetzung.